FI930603L - Aminosubstituerade bensoylguanidiner, foerfaranden foer deras framstaellning, anvaendning av dem som laekemedel samt laekemedel innehaollande desamma - Google Patents

Aminosubstituerade bensoylguanidiner, foerfaranden foer deras framstaellning, anvaendning av dem som laekemedel samt laekemedel innehaollande desamma Download PDF

Info

Publication number: FI930603L
Authority: FI; Finland
Prior art keywords: laekemedel; benzoylguanidiner; aminosubstituerade; anvaendning; samt
Prior art date: 1992-02-15

Application number

FI930603A

Other languages

English (en)

Other versions

FI930603A0 (fi

Inventor

Heinrich Englert

Dieter Mania

Hans-Jochen Lang

Wolfgang Scholz

Wolfgang Linz

Udo Albus

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-15

Filing date

1993-02-11

Publication date

1993-08-16

1993-02-11 Application filed by Hoechst Ag filed Critical Hoechst Ag

1993-02-11 Publication of FI930603A0 publication Critical patent/FI930603A0/fi

1993-08-16 Publication of FI930603L publication Critical patent/FI930603L/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Gastroenterology & Hepatology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

FI930603A 1992-02-15 1993-02-11 Aminosubstituerade bensoylguanidiner, foerfaranden foer deras framstaellning, anvaendning av dem som laekemedel samt laekemedel innehaollande desamma FI930603L (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4204577		1992-02-15

Publications (2)

Publication Number	Publication Date
FI930603A0 FI930603A0 (fi)	1993-02-11
FI930603L true FI930603L (fi)	1993-08-16

Family

ID=6451809

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI930603A FI930603L (fi)	1992-02-15	1993-02-11	Aminosubstituerade bensoylguanidiner, foerfaranden foer deras framstaellning, anvaendning av dem som laekemedel samt laekemedel innehaollande desamma

Country Status (24)

Country	Link
US (1)	US5364868A (fi)
EP (1)	EP0556672B1 (fi)
JP (1)	JP3321473B2 (fi)
KR (1)	KR100275603B1 (fi)
AT (1)	ATE156485T1 (fi)
AU (1)	AU658261B2 (fi)
CA (1)	CA2089442C (fi)
CZ (1)	CZ284456B6 (fi)
DE (1)	DE59307039D1 (fi)
DK (1)	DK0556672T3 (fi)
ES (1)	ES2104971T3 (fi)
FI (1)	FI930603L (fi)
GR (1)	GR3024731T3 (fi)
HU (1)	HU215851B (fi)
IL (1)	IL104715A (fi)
MA (1)	MA22798A1 (fi)
MX (1)	MX9300784A (fi)
NO (1)	NO302029B1 (fi)
NZ (1)	NZ245896A (fi)
PH (1)	PH30940A (fi)
RO (1)	RO114131B1 (fi)
RU (1)	RU2085555C1 (fi)
TW (1)	TW224455B (fi)
ZA (1)	ZA93986B (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW250479B (fi) *	1992-12-15	1995-07-01	Hoechst Ag
EP0612723B1 (de) *	1993-02-20	1997-08-27	Hoechst Aktiengesellschaft	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament
US6190894B1 (en)	1993-03-19	2001-02-20	The Regents Of The University Of California	Method and compositions for disrupting the epithelial barrier function
US6169107B1 (en)	1993-04-28	2001-01-02	Sumitomo Pharmaceutical Co., Ltd.	Indoloylguanidine derivatives
IL109570A0 (en) *	1993-05-17	1994-08-26	Fujisawa Pharmaceutical Co	Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4318658A1 (de) *	1993-06-04	1994-12-08	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) *	1993-06-05	1994-12-08	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4325822A1 (de) *	1993-07-31	1995-02-02	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4337611A1 (de) *	1993-11-04	1995-05-11	Boehringer Ingelheim Kg	Neue Benzoylguanidine, ihre Herstellung und ihre Verwendung in Arzneimitteln
TW415937B (en) *	1994-01-25	2000-12-21	Hoechst Ag	Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4404183A1 (de) *	1994-02-10	1995-08-17	Merck Patent Gmbh	4-Amino-1-piperidylbenzoylguanidine
DE4412334A1 (de) *	1994-04-11	1995-10-19	Hoechst Ag	Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4415873A1 (de) *	1994-05-05	1995-11-09	Hoechst Ag	Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421495A1 (de) *	1994-06-20	1995-12-21	Merck Patent Gmbh	Heterocyclyloxy-benzoylguanidine
IL114670A0 (en) *	1994-08-05	1995-11-27	Fujisawa Pharmaceutical Co	Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
DE4430213A1 (de) *	1994-08-28	1996-02-29	Merck Patent Gmbh	Arylbenzoylguanidine
DE4430861A1 (de) *	1994-08-31	1996-03-07	Merck Patent Gmbh	Heterocyclyl-benzoylguanidine
DE4430916A1 (de) *	1994-08-31	1996-03-07	Merck Patent Gmbh	Alkyl-benzoylguanidin-Derivate
DE4432101A1 (de) *	1994-09-09	1996-03-14	Hoechst Ag	Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4441880A1 (de) *	1994-11-24	1996-05-30	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
TW372967B (en) *	1994-12-27	1999-11-01	Kanebo Ltd	1,4 benzoxazine derivative, pharmaceutical composition containing the same and use thereof
DE19527305A1 (de) *	1995-07-26	1997-01-30	Hoechst Ag	Substituierte Zimtsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0765868A1 (de) *	1995-09-27	1997-04-02	Hoechst Aktiengesellschaft	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarhythmika oder als Diagnostikum sowie sie enthaltendes Medikament
EP0765867A1 (de) *	1995-09-27	1997-04-02	Hoechst Aktiengesellschaft	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament
DE19540995A1 (de) *	1995-11-03	1997-05-07	Hoechst Ag	Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) *	1995-11-14	1997-05-15	Hoechst Ag	Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316439A1 (en) *	1995-11-20	1997-05-26	Hoechst Ag	Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) *	1995-12-14	1997-06-19	Hoechst Ag	Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
US6258829B1 (en)	1997-03-06	2001-07-10	Toa Eiyo Ltd.	Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
DE19737463A1 (de) *	1997-08-28	1999-03-04	Hoechst Marion Roussel De Gmbh	Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
DE19738604A1 (de)	1997-09-04	1999-03-11	Hoechst Marion Roussel De Gmbh	Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verminderung der Giftigkeit cardiotoxischer Stoffe
DE19919349A1 (de) *	1999-04-28	2000-11-02	Merck Patent Gmbh	Verfahren zur Herstellung eines Benzoylguanidinderivates
FR2842804B1 (fr)	2002-07-29	2004-09-03	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861071B1 (fr)	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
FR2906251B1 (fr)	2006-09-22	2008-11-07	Sanofi Aventis Sa	Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3055882A (en) *	1959-06-10	1962-09-25	Ciba Geigy Corp	Reduction process for preparation of cyclic nitrogen compounds
US3780027A (en) *	1970-04-29	1973-12-18	Merck & Co Inc	Anthranilic acid derivatives
US3968243A (en) *	1970-06-05	1976-07-06	Burroughs Wellcome Co.	Substituted guanidine compounds in the treating of arrythmias
DE2931735A1 (de) *	1979-08-04	1981-02-19	Beiersdorf Ag	Neue substituierte phenylacetylguanidine und verfahren zu ihrer herstellung
DE3360148D1 (en) *	1982-02-10	1985-06-05	Beecham Group Plc	Guanidine derivatives
US5190976A (en) *	1986-07-10	1993-03-02	State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And University Of Oregon	N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
DE3929582A1 (de) *	1989-09-06	1991-03-07	Hoechst Ag	Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
US5006523A (en) *	1989-10-26	1991-04-09	E. R. Squibb & Sons, Inc.	Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
ES2089600T3 (es) *	1992-02-15	1996-10-01	Hoechst Ag	Benzoilguanidina sustituida en 3,5, con efecto antiarritmico y efecto inhibidor de la proliferacion de celulas.
ES2108144T3 (es) *	1992-02-15	1997-12-16	Hoechst Ag	Benzoilguanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
DE59306029D1 (de) *	1992-12-16	1997-05-07	Hoechst Ag	3,5-Substituierte Aminobenzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

1992
- 1992-12-31 CZ CS924033A patent/CZ284456B6/cs unknown
1993
- 1993-02-05 DK DK93101840.2T patent/DK0556672T3/da active
- 1993-02-05 AT AT93101840T patent/ATE156485T1/de not_active IP Right Cessation
- 1993-02-05 ES ES93101840T patent/ES2104971T3/es not_active Expired - Lifetime
- 1993-02-05 EP EP93101840A patent/EP0556672B1/de not_active Expired - Lifetime
- 1993-02-05 DE DE59307039T patent/DE59307039D1/de not_active Expired - Lifetime
- 1993-02-05 TW TW082100767A patent/TW224455B/zh active
- 1993-02-11 RO RO93-00173A patent/RO114131B1/ro unknown
- 1993-02-11 FI FI930603A patent/FI930603L/fi unknown
- 1993-02-11 US US08/016,535 patent/US5364868A/en not_active Expired - Lifetime
- 1993-02-12 MX MX9300784A patent/MX9300784A/es unknown
- 1993-02-12 HU HU9300368A patent/HU215851B/hu not_active IP Right Cessation
- 1993-02-12 RU RU93004698/04A patent/RU2085555C1/ru not_active IP Right Cessation
- 1993-02-12 PH PH45720A patent/PH30940A/en unknown
- 1993-02-12 MA MA23090A patent/MA22798A1/fr unknown
- 1993-02-12 IL IL104715A patent/IL104715A/en not_active IP Right Cessation
- 1993-02-12 CA CA002089442A patent/CA2089442C/en not_active Expired - Fee Related
- 1993-02-12 JP JP02310993A patent/JP3321473B2/ja not_active Expired - Lifetime
- 1993-02-12 NZ NZ245896A patent/NZ245896A/en unknown
- 1993-02-12 ZA ZA93986A patent/ZA93986B/xx unknown
- 1993-02-12 AU AU33013/93A patent/AU658261B2/en not_active Ceased
- 1993-02-12 NO NO930512A patent/NO302029B1/no not_active IP Right Cessation
- 1993-02-15 KR KR1019930002037A patent/KR100275603B1/ko not_active Expired - Fee Related
1997
- 1997-09-16 GR GR970402375T patent/GR3024731T3/el unknown

Also Published As

Publication number	Publication date
JPH0641049A (ja)	1994-02-15
MX9300784A (es)	1993-09-01
CZ403392A3 (en)	1993-12-15
US5364868A (en)	1994-11-15
CA2089442C (en)	2005-08-23
CZ284456B6 (cs)	1998-12-16
HU215851B (hu)	2000-06-28
ES2104971T3 (es)	1997-10-16
TW224455B (fi)	1994-06-01
KR930017868A (ko)	1993-09-20
IL104715A (en)	1998-02-08
AU3301393A (en)	1993-08-19
NZ245896A (en)	1995-04-27
EP0556672A1 (de)	1993-08-25
DK0556672T3 (da)	1998-03-02
DE59307039D1 (de)	1997-09-11
RO114131B1 (ro)	1999-01-29
ZA93986B (en)	1993-09-20
NO930512D0 (no)	1993-02-12
KR100275603B1 (ko)	2000-12-15
FI930603A0 (fi)	1993-02-11
PH30940A (en)	1997-12-23
MA22798A1 (fr)	1993-10-01
GR3024731T3 (en)	1997-12-31
ATE156485T1 (de)	1997-08-15
AU658261B2 (en)	1995-04-06
HU9300368D0 (en)	1993-04-28
NO930512L (no)	1993-08-16
IL104715A0 (en)	1993-06-10
HUT63379A (en)	1993-08-30
EP0556672B1 (de)	1997-08-06
CA2089442A1 (en)	1993-08-16
NO302029B1 (no)	1998-01-12
RU2085555C1 (ru)	1997-07-27
JP3321473B2 (ja)	2002-09-03

Publication	Publication Date	Title
FI930603L (fi)	1993-08-16	Aminosubstituerade bensoylguanidiner, foerfaranden foer deras framstaellning, anvaendning av dem som laekemedel samt laekemedel innehaollande desamma
FI930989A (fi)	1993-09-08	Foerfarande foer tillverkning av byggelement foer ljusvaogsledningsnaetverk, samt byggelement som tillverkats enligt foerfarandet
FI930602L (fi)	1993-08-16	Ortosubstituerade bensoylguanidiner, foerfarande foer framstaellning av dessa, anvaendning av dessa som laekemedel eller diagnostiska aemnen samt laekemedel innehaollande desamma
FI931278L (fi)	1993-09-26	Polymerer, som innehaoller sulfogrupper
FI932998L (fi)	1994-01-02	3,4,5-substituerade bensoylguanidiner, foerfarande foer deras framstaellning, deras anvaendning som laekemedel eller diagnostiskt medel samt laekemedel innehaollande dem
FI894101A0 (fi)	1989-08-31	Amidderivat, deras framstaellningsfoerfarande samt fungisida sammansaettningar innehaollande dem.
FI934409L (fi)	1994-04-09	Klocka som anpassats att mottaga med radiosignaler saenda budskap, som med hjaelp av klockans visare
FI933274L (fi)	1994-01-23	Tvaerbundna, kvaevehaltiga vinylkopolymerer, foerfarande foer framstaellning av dessa samt anvaendning av dessa
FI932527L (fi)	1993-12-05	Anvaendning av polypropylenglykol saosom tillsatsaemne, som reducerar krympningens storlek i dispersionspulversammansaettningar avsedda foer byggmaterialer
FI931040L (fi)	1993-09-11	Kompositioner av slumpartade sampolymerer av propen, vilka innehaoller en a-olefin som komonomer
FI922235L (fi)	1992-11-17	Foerfarande foer framstaellning av 3-aminopyridazinderivat, som verkar paodet centrala nervsystemet
FI925734L (fi)	1993-06-21	Polyaspartamidderivat som adsorptionsmedel foer gallsyra, polyaspartamidderivat innehaollande gallsyror och foerfarande foer framstaellning av dessa samt anvaendning av dessa som laekemedel
FI925993L (fi)	1993-07-01	Katjoniska polymerer, som filtrations fraemjande tillaegsmedel samt som stabilatorer i hartsinnehaollande papperslim
FI89753B (fi)	1993-07-30	Foerfarande foer kontroll av en betalanordning foer parkering, en betalanordning samt en anordning foer kontroll av densamma
FI924066A0 (fi)	1992-09-11	Foerfarande foer avkylning av gas i en anlaeggning som utnyttjar luftgas samt anlaeggning.
FI935181L (fi)	1993-11-22	Byggnadsserie bestaoende av formstenar av betong samt massiv stoedmur byggd av dem
FI891712L (fi)	1989-10-13	Terapeutiskt aktiva aminer av cyklometylen-1,2-bikarboxylsyror, foerfaranden foer deras framstaellning samt farmaceutiska kompositioner innehaollande dem.
FI935192L (fi)	1993-12-10	Substituerade benzotiazolderivat, deras framstaellning samt anvaendning som herbicider
FI930722A0 (fi)	1993-02-18	Foerfarande foer framstaellning av polymerer som innehaoller ammoniumgrupper
FI933541A0 (fi)	1993-08-11	Pseudoatseotropiska sammansaettningar av difluorometan, pentafluoroetanoch 1,1,1-trifluoroetan samt deras anvaendning som kylvaetskor vid djupfrysning
FI934764L (fi)	1994-04-30	Anordning som hindrar krympning av kabelisolering
FI921666A0 (fi)	1992-04-14	Indolin- och dihydrokinolinfoereningar som oeppnare av kaliumkanal.
FI931527A0 (fi)	1993-04-05	Foerfarande foer behandling av avfall fraon katodstraolroer, speciellt bildroer, respektive glasdelar av dem
FI890798L (fi)	1989-08-19	Foerfarande foer diacylering av foereningar som innehaoller tvao aromatiska kaernor.
FI893863L (fi)	1990-02-20	Foerfarande foer neutralisering av svavelsyra som innehaoller zinkjoner.